Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues
Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neoplasia (PanIN), display a ductal phenotype. However, there is evidence in genetically defined mouse models for PDAC harbouring a mutated kras under the control of a pancreas‐specific promoter that ductal...
Saved in:
Published in | The Journal of pathology Vol. 226; no. 5; pp. 723 - 734 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.04.2012
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 0022-3417 1096-9896 1096-9896 |
DOI | 10.1002/path.3017 |
Cover
Summary: | Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neoplasia (PanIN), display a ductal phenotype. However, there is evidence in genetically defined mouse models for PDAC harbouring a mutated kras under the control of a pancreas‐specific promoter that ductal cancer might arise in the centroacinar‐acinar region, possibly through a process of acinar‐ductal metaplasia (ADM). In order to further elucidate this model of PDAC development, an extensive expression analysis and molecular characterization of the putative and already established (PanIN) precursor lesions were performed in the Kras$^{G{\it{\bf{12}}}D/+}$ ; Ptf1a‐Cre$^{ex{\it{\bf{1}}}/+}$ mouse model and in human tissues, focusing on lineage markers, developmental pathways, cell cycle regulators, apomucins, and stromal activation markers. The results of this study show that areas of ADM are very frequent in the murine and human pancreas and represent regions of increased proliferation of cells with precursor potential. Moreover, atypical flat lesions originating in areas of ADM are the most probable precursors of PDAC in the Kras$^{G{\it{\bf{12}}}D/+}$; Ptf1a‐Cre$^{ex{\it{\bf{1}}}/+}$ mice and similar lesions were also found in the pancreas of three patients with a strong family history of PDAC. In conclusion, PDAC development in Kras$^{G{\it{\bf{12}}}D/+}$; Ptf1a‐Cre$^{ex{\it{\bf{1}}}/+}$ mice starts from ADM and a similar process might also take place in patients with a strong family history of PDAC. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
---|---|
Bibliography: | Supporting Information: Supplementary materials and methodsSupporting Information: Table S1. Clinical data and selection criteria of three patients with a FPC background.Supporting Information: Table S2. Antibodies and protocols for immunohistochemistry.Supporting Information: Table S3. Quantification of immunohistochemical parameters.Supporting Information: Figure S1. Mouse genotyping scheme.Supporting Information: Figure S2. Genetic analysis of mouse tissues.Supporting Information: Figure S3. Genetic analysis of a microdissected lesion in a FPC patient.Supporting Information: Legends to Figure S1 to S3 istex:E195D6FD98399CA36E7D5DDC34BF27AEA5F08546 ArticleID:PATH3017 No conflicts of interest were declared. ark:/67375/WNG-PF3QFJJH-5 These authors contributed equally to this work. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0022-3417 1096-9896 1096-9896 |
DOI: | 10.1002/path.3017 |